Blood Pressure and Development of Cardiovascular Disease in Koreans With Type 2 Diabetes Mellitus

The objective of this study was to investigate the optimal blood pressure (BP) target to prevent development of cardiovascular diseases (CVDs) in Korean subjects with type 2 diabetes mellitus. Using the Korean National Health Insurance Service database, 2 262 725 subjects with type 2 diabetes mellit...

Full description

Saved in:
Bibliographic Details
Published inHypertension (Dallas, Tex. 1979) Vol. 73; no. 2; pp. 319 - 326
Main Authors Kim, Mee Kyoung, Han, Kyungdo, Koh, Eun Sil, Kim, Eun Sook, Lee, Min-Kyung, Nam, Ga Eun, Kwon, Hyuk-Sang
Format Journal Article
LanguageEnglish
Published United States American Heart Association, Inc 01.02.2019
Subjects
Online AccessGet full text
ISSN0194-911X
1524-4563
1524-4563
DOI10.1161/HYPERTENSIONAHA.118.12160

Cover

Abstract The objective of this study was to investigate the optimal blood pressure (BP) target to prevent development of cardiovascular diseases (CVDs) in Korean subjects with type 2 diabetes mellitus. Using the Korean National Health Insurance Service database, 2 262 725 subjects with type 2 diabetes mellitus who underwent regular health checks between 2009 and 2012 were included. Subjects with previous CVDs were excluded. Participants were grouped by 10-mm Hg intervals of observed systolic BP (SBP) by 5-mm Hg intervals of diastolic BP. There were 124 466 deaths (5.50%), 67 235 cases of stroke (2.97%), and 41 726 myocardial infarctions (1.84%) during a median follow-up of 6.5 years. Compared with SBP 110 to 119 mm Hg, there was no increased risk among subjects with SBP 120 to 129 mm Hg, but SBP ≥130 mm Hg was associated with a significant increase in the incidence of CVDs. SBP 130 to 139 mm Hg was associated with a significant increase in the incidence of stroke (hazard ratio, 1.15; 95% CI, 1.12–1.18) and myocardial infarctions (hazard ratio, 1.05; 95% CI, 1.02–1.09) compared with SBP 110 to 119 mm Hg. Subjects with diastolic BP 80 to 84 mm Hg had a higher risk of CVDs than subjects with diastolic BP 75 to 79 mm Hg. The overall relationship between BP and CVD risk was positive, with a greater strength observed for younger age groups. The optimal cutoff for Korean patients with type 2 diabetes mellitus associated with lower CVD risk may be 130 mm Hg for SBP or 80 mm Hg for diastolic BP.
AbstractList The objective of this study was to investigate the optimal blood pressure (BP) target to prevent development of cardiovascular diseases (CVDs) in Korean subjects with type 2 diabetes mellitus. Using the Korean National Health Insurance Service database, 2 262 725 subjects with type 2 diabetes mellitus who underwent regular health checks between 2009 and 2012 were included. Subjects with previous CVDs were excluded. Participants were grouped by 10-mm Hg intervals of observed systolic BP (SBP) by 5-mm Hg intervals of diastolic BP. There were 124 466 deaths (5.50%), 67 235 cases of stroke (2.97%), and 41 726 myocardial infarctions (1.84%) during a median follow-up of 6.5 years. Compared with SBP 110 to 119 mm Hg, there was no increased risk among subjects with SBP 120 to 129 mm Hg, but SBP ≥130 mm Hg was associated with a significant increase in the incidence of CVDs. SBP 130 to 139 mm Hg was associated with a significant increase in the incidence of stroke (hazard ratio, 1.15; 95% CI, 1.12–1.18) and myocardial infarctions (hazard ratio, 1.05; 95% CI, 1.02–1.09) compared with SBP 110 to 119 mm Hg. Subjects with diastolic BP 80 to 84 mm Hg had a higher risk of CVDs than subjects with diastolic BP 75 to 79 mm Hg. The overall relationship between BP and CVD risk was positive, with a greater strength observed for younger age groups. The optimal cutoff for Korean patients with type 2 diabetes mellitus associated with lower CVD risk may be 130 mm Hg for SBP or 80 mm Hg for diastolic BP.
The objective of this study was to investigate the optimal blood pressure (BP) target to prevent development of cardiovascular diseases (CVDs) in Korean subjects with type 2 diabetes mellitus. Using the Korean National Health Insurance Service database, 2 262 725 subjects with type 2 diabetes mellitus who underwent regular health checks between 2009 and 2012 were included. Subjects with previous CVDs were excluded. Participants were grouped by 10-mm Hg intervals of observed systolic BP (SBP) by 5-mm Hg intervals of diastolic BP. There were 124 466 deaths (5.50%), 67 235 cases of stroke (2.97%), and 41 726 myocardial infarctions (1.84%) during a median follow-up of 6.5 years. Compared with SBP 110 to 119 mm Hg, there was no increased risk among subjects with SBP 120 to 129 mm Hg, but SBP ≥130 mm Hg was associated with a significant increase in the incidence of CVDs. SBP 130 to 139 mm Hg was associated with a significant increase in the incidence of stroke (hazard ratio, 1.15; 95% CI, 1.12-1.18) and myocardial infarctions (hazard ratio, 1.05; 95% CI, 1.02-1.09) compared with SBP 110 to 119 mm Hg. Subjects with diastolic BP 80 to 84 mm Hg had a higher risk of CVDs than subjects with diastolic BP 75 to 79 mm Hg. The overall relationship between BP and CVD risk was positive, with a greater strength observed for younger age groups. The optimal cutoff for Korean patients with type 2 diabetes mellitus associated with lower CVD risk may be 130 mm Hg for SBP or 80 mm Hg for diastolic BP.The objective of this study was to investigate the optimal blood pressure (BP) target to prevent development of cardiovascular diseases (CVDs) in Korean subjects with type 2 diabetes mellitus. Using the Korean National Health Insurance Service database, 2 262 725 subjects with type 2 diabetes mellitus who underwent regular health checks between 2009 and 2012 were included. Subjects with previous CVDs were excluded. Participants were grouped by 10-mm Hg intervals of observed systolic BP (SBP) by 5-mm Hg intervals of diastolic BP. There were 124 466 deaths (5.50%), 67 235 cases of stroke (2.97%), and 41 726 myocardial infarctions (1.84%) during a median follow-up of 6.5 years. Compared with SBP 110 to 119 mm Hg, there was no increased risk among subjects with SBP 120 to 129 mm Hg, but SBP ≥130 mm Hg was associated with a significant increase in the incidence of CVDs. SBP 130 to 139 mm Hg was associated with a significant increase in the incidence of stroke (hazard ratio, 1.15; 95% CI, 1.12-1.18) and myocardial infarctions (hazard ratio, 1.05; 95% CI, 1.02-1.09) compared with SBP 110 to 119 mm Hg. Subjects with diastolic BP 80 to 84 mm Hg had a higher risk of CVDs than subjects with diastolic BP 75 to 79 mm Hg. The overall relationship between BP and CVD risk was positive, with a greater strength observed for younger age groups. The optimal cutoff for Korean patients with type 2 diabetes mellitus associated with lower CVD risk may be 130 mm Hg for SBP or 80 mm Hg for diastolic BP.
Author Kim, Mee Kyoung
Han, Kyungdo
Nam, Ga Eun
Koh, Eun Sil
Kim, Eun Sook
Lee, Min-Kyung
Kwon, Hyuk-Sang
AuthorAffiliation From the Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary’s Hospital (M.K.K., H.-S.K.), College of Medicine, Catholic University of Korea, Seoul Department of Medical Statistics (K.H.), College of Medicine, Catholic University of Korea, Seoul Division of Nephrology, Department of Internal Medicine, Yeouido St. Mary’s Hospital (E.S. Koh), College of Medicine, Catholic University of Korea, Seoul Division of Endocrinology and Metabolism, Department of Internal Medicine, Incheon St. Mary’s Hospital (E.S. Kim), College of Medicine, Catholic University of Korea, Seoul Division of Endocrinology and Metabolism, Department of Internal Medicine, Myongji Hospital, Hanyang University Medical Center, Goyang-Si, Korea (M.-K.L.) Department of Family Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul (G.E.N.)
AuthorAffiliation_xml – name: From the Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary’s Hospital (M.K.K., H.-S.K.), College of Medicine, Catholic University of Korea, Seoul Department of Medical Statistics (K.H.), College of Medicine, Catholic University of Korea, Seoul Division of Nephrology, Department of Internal Medicine, Yeouido St. Mary’s Hospital (E.S. Koh), College of Medicine, Catholic University of Korea, Seoul Division of Endocrinology and Metabolism, Department of Internal Medicine, Incheon St. Mary’s Hospital (E.S. Kim), College of Medicine, Catholic University of Korea, Seoul Division of Endocrinology and Metabolism, Department of Internal Medicine, Myongji Hospital, Hanyang University Medical Center, Goyang-Si, Korea (M.-K.L.) Department of Family Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul (G.E.N.)
– name: From the Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary’s Hospital, College of Medicine, Catholic University of Korea, Seoul (M.K.K., H.-S.K.) Department of Medical Statistics, College of Medicine, Catholic University of Korea, Seoul (K.H.) Division of Nephrology, Department of Internal Medicine, Yeouido St. Mary’s Hospital, College of Medicine, Catholic University of Korea, Seoul (E.S. Koh) Division of Endocrinology and Metabolism, Department of Internal Medicine, Incheon St. Mary’s Hospital, College of Medicine, Catholic University of Korea, Seoul (E.S. Kim) Division of Endocrinology and Metabolism, Department of Internal Medicine, Myongji Hospital, Hanyang University Medical Center, Goyang-Si, Korea (M.-K.L.) Department of Family Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul (G.E.N.)
Author_xml – sequence: 1
  givenname: Mee
  surname: Kim
  middlename: Kyoung
  fullname: Kim, Mee Kyoung
  organization: From the Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary’s Hospital (M.K.K., H.-S.K.), College of Medicine, Catholic University of Korea, Seoul Department of Medical Statistics (K.H.), College of Medicine, Catholic University of Korea, Seoul Division of Nephrology, Department of Internal Medicine, Yeouido St. Mary’s Hospital (E.S. Koh), College of Medicine, Catholic University of Korea, Seoul Division of Endocrinology and Metabolism, Department of Internal Medicine, Incheon St. Mary’s Hospital (E.S. Kim), College of Medicine, Catholic University of Korea, Seoul Division of Endocrinology and Metabolism, Department of Internal Medicine, Myongji Hospital, Hanyang University Medical Center, Goyang-Si, Korea (M.-K.L.) Department of Family Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul (G.E.N.)
– sequence: 2
  givenname: Kyungdo
  surname: Han
  fullname: Han, Kyungdo
– sequence: 3
  givenname: Eun
  surname: Koh
  middlename: Sil
  fullname: Koh, Eun Sil
– sequence: 4
  givenname: Eun
  surname: Kim
  middlename: Sook
  fullname: Kim, Eun Sook
– sequence: 5
  givenname: Min-Kyung
  surname: Lee
  fullname: Lee, Min-Kyung
– sequence: 6
  givenname: Ga
  surname: Nam
  middlename: Eun
  fullname: Nam, Ga Eun
– sequence: 7
  givenname: Hyuk-Sang
  surname: Kwon
  fullname: Kwon, Hyuk-Sang
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30624985$$D View this record in MEDLINE/PubMed
BookMark eNqNUk1P3DAQtSpQWWj_QuXeegn4K05yqKpl2bKoFBBs1fZkOclY69Ybb20HxL-vy8KFQ4WlkTXj996M5nkf7Qx-AITeU3JIqaRHi59X8-vl_OLm7PJiupjmYn1IGZXkFZrQkolClJLvoAmhjSgaSn_sof0YfxFChRDVa7THiWSiqcsJ0sfO-x5fBYhxDID10OMTuAXnN2sYEvYGz3Torb_VsRudDvjERtARsB3wFx9ADxF_t2mFl_cbwCw_6xYSRPwVnLNpjG_QrtEuwtvH-wB9-zxfzhbF-eXp2Wx6XnQiT140rJWVqXnPqWk62rSSMtDG9G2vGRBumClNU1V9zUxHGNBSdqTtuOC9MFxKfoA-bHU3wf8ZISa1trHLQ-gB_BgVo1XDWVnVPEPfPULHdg292gS71uFePa0lAz5tAV3wMQYwqrNJJ-uHFLR1ihL1zwj1zIhcrNWDEVmheabw1OQl3I9b7p13CUL87cY7CGoF2qXVi_jiP3ySj2CyLlj-HoTlrMhBJf8LLLey6g
CitedBy_id crossref_primary_10_2147_RMHP_S385815
crossref_primary_10_1186_s12933_019_0953_7
crossref_primary_10_4070_kcj_2020_0171
crossref_primary_10_1002_jhbp_12109
crossref_primary_10_1089_thy_2019_0543
crossref_primary_10_1161_HYPERTENSIONAHA_120_15320
crossref_primary_10_1161_JAHA_123_030772
crossref_primary_10_1007_s15006_019_0707_1
crossref_primary_10_1097_PRS_0000000000011297
crossref_primary_10_1111_jdi_13539
crossref_primary_10_4078_jrd_2023_0011
crossref_primary_10_4093_dmj_2019_0137
crossref_primary_10_1161_JAHA_120_017475
crossref_primary_10_1186_s12933_022_01705_3
crossref_primary_10_1161_CIRCEP_119_007428
crossref_primary_10_1038_s41366_021_00922_2
crossref_primary_10_12997_jla_2021_10_3_303
crossref_primary_10_1007_s15027_019_1544_y
crossref_primary_10_1016_j_jocn_2024_03_004
crossref_primary_10_4093_jkd_2020_21_1_27
crossref_primary_10_1097_HJH_0000000000002980
crossref_primary_10_1016_j_diabres_2020_108157
crossref_primary_10_1038_s41598_021_81328_y
crossref_primary_10_1186_s12933_019_0943_9
crossref_primary_10_1016_j_lanwpc_2020_100085
crossref_primary_10_1161_JAHA_120_017783
crossref_primary_10_1111_dom_15710
crossref_primary_10_1038_s41598_024_51757_6
crossref_primary_10_1371_journal_pone_0299035
crossref_primary_10_3346_jkms_2020_35_e312
crossref_primary_10_1371_journal_pone_0262757
Cites_doi 10.1111/jdi.12810
10.1093/eurheartj/ehx585
10.1002/sim.7144
10.4070/kcj.2017.0036
10.1001/jamacardio.2016.2861
10.1111/jch.12009
10.1097/01.hjh.0000431740.32696.cc
10.1097/01.hjh.0000052492.18130.07
10.3803/EnM.2014.29.4.405
10.1258/0004563054889936
10.1161/01.ATV.0000160548.78317.29
10.1161/01.CIR.100.4.354
10.1001/jama.2014.18574
10.1056/NEJMoa1511939
10.1161/HYPERTENSIONAHA.117.10034
10.1253/circj.CJ-13-0786
10.1016/j.amjhyper.2005.06.024
10.2337/dc18-S009
10.4093/dmj.2018.42.2.93
10.1161/HYPERTENSIONAHA.111.00289
10.2337/dc17-2443
10.3803/EnM.2015.30.4.522
10.1001/archinte.167.19.2139
10.1016/S2213-8587(17)30327-3
10.4093/dmj.2016.40.1.79
10.1291/hypres.31.2115
10.1056/NEJM200006223422506
10.1161/01.hyp.23.3.395
10.2337/dc17-1366
ContentType Journal Article
Copyright 2019 American Heart Association, Inc
2018 American Heart Association, Inc
Copyright_xml – notice: 2019 American Heart Association, Inc
– notice: 2018 American Heart Association, Inc
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1161/HYPERTENSIONAHA.118.12160
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
CrossRef
PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4563
EndPage 326
ExternalDocumentID 30624985
10_1161_HYPERTENSIONAHA_118_12160
10.1161/HYPERTENSIONAHA.118.12160
00004268-201902000-00016
Genre Journal Article
GroupedDBID ---
.-D
.3C
.55
.GJ
.XZ
.Z2
01R
0R~
18M
1J1
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAAXR
AAFWJ
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AAXQO
AAYEP
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABPXF
ABQRW
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFBFQ
AFDTB
AFEXH
AFFNX
AFNMH
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHQVU
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BAWUL
BCGUY
BOYCO
BQLVK
BS7
C1A
C45
CS3
DIK
DIWNM
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GNXGY
GQDEL
GX1
H0~
H13
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
JF9
JG8
JK3
JK8
K-A
K-F
K8S
KD2
KMI
KQ8
L-C
L7B
N4W
N9A
N~7
N~B
N~M
O9-
OAG
OAH
OB3
OCUKA
ODA
ODMTH
OGROG
OHYEH
OK1
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PQQKQ
R58
RAH
RIG
RLZ
S4R
S4S
T8P
TEORI
TR2
TSPGW
V2I
VVN
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YHZ
YOC
YYM
YYP
ZFV
ZGI
ZZMQN
AAYXX
ADGHP
ADKSD
ADSXY
CITATION
OZ-
ACIJW
AWKKM
NPM
OLW
RHF
7X8
ID FETCH-LOGICAL-c4160-92b67f83d31f9c19b612eaffdbda2e03f2f5f977d82fc02e156c0bc343d4f3663
ISSN 0194-911X
1524-4563
IngestDate Mon Sep 08 07:17:08 EDT 2025
Wed Feb 19 02:34:25 EST 2025
Wed Oct 01 02:26:28 EDT 2025
Thu Apr 24 22:56:08 EDT 2025
Fri May 16 03:57:17 EDT 2025
Fri May 16 04:02:50 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords blood pressure
diabetes mellitus
cardiovascular diseases
hypertension
Korea
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4160-92b67f83d31f9c19b612eaffdbda2e03f2f5f977d82fc02e156c0bc343d4f3663
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 30624985
PQID 2179325783
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_2179325783
pubmed_primary_30624985
crossref_citationtrail_10_1161_HYPERTENSIONAHA_118_12160
crossref_primary_10_1161_HYPERTENSIONAHA_118_12160
wolterskluwer_health_10_1161_HYPERTENSIONAHA_118_12160
wolterskluwer_health_00004268-201902000-00016
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-February
PublicationDateYYYYMMDD 2019-02-01
PublicationDate_xml – month: 02
  year: 2019
  text: 2019-February
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Hypertension (Dallas, Tex. 1979)
PublicationTitleAlternate Hypertension
PublicationYear 2019
Publisher American Heart Association, Inc
Publisher_xml – name: American Heart Association, Inc
References e_1_3_4_3_2
e_1_3_4_2_2
e_1_3_4_9_2
e_1_3_4_8_2
e_1_3_4_7_2
e_1_3_4_6_2
e_1_3_4_5_2
e_1_3_4_4_2
e_1_3_4_22_2
e_1_3_4_23_2
e_1_3_4_20_2
e_1_3_4_21_2
e_1_3_4_26_2
e_1_3_4_27_2
e_1_3_4_24_2
e_1_3_4_25_2
e_1_3_4_28_2
e_1_3_4_29_2
National Kidney Foundation (e_1_3_4_15_2) 2002; 39
e_1_3_4_30_2
e_1_3_4_11_2
e_1_3_4_12_2
e_1_3_4_10_2
e_1_3_4_31_2
e_1_3_4_16_2
e_1_3_4_13_2
e_1_3_4_14_2
e_1_3_4_19_2
e_1_3_4_17_2
e_1_3_4_18_2
References_xml – ident: e_1_3_4_31_2
  doi: 10.1111/jdi.12810
– ident: e_1_3_4_11_2
  doi: 10.1093/eurheartj/ehx585
– ident: e_1_3_4_25_2
  doi: 10.1002/sim.7144
– ident: e_1_3_4_26_2
  doi: 10.4070/kcj.2017.0036
– ident: e_1_3_4_8_2
  doi: 10.1001/jamacardio.2016.2861
– ident: e_1_3_4_27_2
  doi: 10.1111/jch.12009
– ident: e_1_3_4_3_2
  doi: 10.1097/01.hjh.0000431740.32696.cc
– ident: e_1_3_4_18_2
  doi: 10.1097/01.hjh.0000052492.18130.07
– ident: e_1_3_4_12_2
  doi: 10.3803/EnM.2014.29.4.405
– ident: e_1_3_4_14_2
  doi: 10.1258/0004563054889936
– ident: e_1_3_4_22_2
  doi: 10.1161/01.ATV.0000160548.78317.29
– ident: e_1_3_4_23_2
  doi: 10.1161/01.CIR.100.4.354
– ident: e_1_3_4_30_2
  doi: 10.1001/jama.2014.18574
– ident: e_1_3_4_4_2
  doi: 10.1056/NEJMoa1511939
– ident: e_1_3_4_17_2
  doi: 10.1161/HYPERTENSIONAHA.117.10034
– ident: e_1_3_4_19_2
  doi: 10.1253/circj.CJ-13-0786
– ident: e_1_3_4_20_2
  doi: 10.1016/j.amjhyper.2005.06.024
– ident: e_1_3_4_2_2
  doi: 10.2337/dc18-S009
– ident: e_1_3_4_9_2
  doi: 10.4093/dmj.2018.42.2.93
– ident: e_1_3_4_29_2
  doi: 10.1161/HYPERTENSIONAHA.111.00289
– ident: e_1_3_4_16_2
  doi: 10.2337/dc17-2443
– ident: e_1_3_4_13_2
  doi: 10.3803/EnM.2015.30.4.522
– ident: e_1_3_4_28_2
  doi: 10.1001/archinte.167.19.2139
– volume: 39
  start-page: S1
  year: 2002
  ident: e_1_3_4_15_2
  article-title: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.
  publication-title: Am J Kidney Dis
– ident: e_1_3_4_6_2
  doi: 10.1016/S2213-8587(17)30327-3
– ident: e_1_3_4_10_2
  doi: 10.4093/dmj.2016.40.1.79
– ident: e_1_3_4_21_2
  doi: 10.1291/hypres.31.2115
– ident: e_1_3_4_7_2
  doi: 10.1056/NEJM200006223422506
– ident: e_1_3_4_24_2
  doi: 10.1161/01.hyp.23.3.395
– ident: e_1_3_4_5_2
  doi: 10.2337/dc17-1366
SSID ssj0014447
Score 2.4470963
Snippet The objective of this study was to investigate the optimal blood pressure (BP) target to prevent development of cardiovascular diseases (CVDs) in Korean...
SourceID proquest
pubmed
crossref
wolterskluwer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 319
Title Blood Pressure and Development of Cardiovascular Disease in Koreans With Type 2 Diabetes Mellitus
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004268-201902000-00016
https://www.ncbi.nlm.nih.gov/pubmed/30624985
https://www.proquest.com/docview/2179325783
Volume 73
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1524-4563
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0014447
  issn: 0194-911X
  databaseCode: KQ8
  dateStart: 19790101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1524-4563
  dateEnd: 20241003
  omitProxy: true
  ssIdentifier: ssj0014447
  issn: 0194-911X
  databaseCode: DIK
  dateStart: 19790101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1524-4563
  dateEnd: 20241003
  omitProxy: true
  ssIdentifier: ssj0014447
  issn: 0194-911X
  databaseCode: GX1
  dateStart: 19790101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZB2VjjN2X3VBhb8GdLcmy_JgtHWYhZYMUsidjyxItG_ZoHbbu9-yH7ujixGla1u7FGKGL0fl8bjpHB6G3ZQFiRCZgqeq0CFiqWFAk1m8lQkpjUUlbh2x2yLMj9mkRLwaDP72opWVb7svfl-aV_A9VoQ3oarJkb0DZ1aTQAO9AX3gCheF5LRq_N1HnPsPPnwP0goBc6tVGuOnEHccYJ8e0AXWxNuGv7fFo7hyxk84ROzPXdLbeJ-BV1wz6nNp4dwsYMTEueBdkpH7tj6I0SXtuBV-leabUaHpuOMqa1Vk-Nz2HtqpZdW-OXdoNcJt10IefxLZ2xoD3UJikqM1oj-7oKYN_t-3DbivcEwYzw34Xff7sSp14HJIes6We2Tq5TV3m_bZI4EYkZF8_H4CBcGgk1DgbQ7MwF2u4WgYXbty2dhPhBmugLnW59xG_hW6ThHNTJ2P6ZX1WxRjzSfnu23fRnl_33ZWrbmpBW6bNXXTvZ2OiJc6-2WSJnsozf4Due1sFjx3wHqKBqh-h3ZmPxniMCos_3OEPA_5wD3-40XgTf9jjD5_U2OMPG_xhgz9McIc_3OHvCTr6eDD_kAW-ZEcgQbMPg5SUPNGCVjTSqYzSEhRoVWhdlVVBVEg10bEGk6MSRMuQqCjmMiwlZbRimoL2-xTt1E2tniMsSi2rmOo4SjjToNcC40hFEcYyobKg6RCJbgtz6e-zN2VVvufWruVRfmH3oVHkdveHiKyG_nCXulxn0F5HpxxYsDlXK2rVLM9yYoScEX10iJ45Aq6mBYucsFTEQxRsUDR3ac75VVgbIn5p_39-5osbLvQS3Vn_s6_QTnu6VK9Bz27LNxbmfwHQpMeT
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Blood+Pressure+and+Development+of+Cardiovascular+Disease+in+Koreans+With+Type+2+Diabetes+Mellitus&rft.jtitle=Hypertension+%28Dallas%2C+Tex.+1979%29&rft.au=Kim%2C+Mee+Kyoung&rft.au=Han%2C+Kyungdo&rft.au=Koh%2C+Eun+Sil&rft.au=Kim%2C+Eun+Sook&rft.date=2019-02-01&rft.pub=American+Heart+Association%2C+Inc&rft.issn=0194-911X&rft.volume=73&rft.issue=2&rft.spage=319&rft.epage=326&rft_id=info:doi/10.1161%2FHYPERTENSIONAHA.118.12160&rft.externalDocID=00004268-201902000-00016
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0194-911X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0194-911X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0194-911X&client=summon